BIOSTATISTICS AND CLINICAL TRIAL METHODOLOGY

original reports

Building Capacity for Cancer Research in
the Era of COVID-19: Implementation and Results
From an International Virtual Clinical Research
Training Program in Zambia
Kevin Diao, MD1; Dorothy C. Lombe, MD, MMED2; Catherine K. Mwaba, MD3; Juliana Wu, BA4; Darya A. Kizub, MD5;
Carrie A. Cameron, PhD6; Elizabeth Y. Chiao, MD, MPH7; Susan C. Msadabwe, MBChB, MMED3; and Lilie L. Lin, MD1

abstract

PURPOSE The incidence of cancer in sub-Saharan Africa is increasing rapidly, yet cancer research in the region
continues to lag. One contributing factor is limited exposure to clinical research among trainees. We describe
implementation and results of a virtual clinical research training program for Zambian clinical oncology fellows
developed jointly by the Cancer Diseases Hospital in Zambia and the MD Anderson Cancer Center to address
this need.
METHODS The clinical research training program consisted of 14 weekly virtual lectures, development of research questions by Zambian clinical oncology fellows, assignment of faculty and peer mentors, longitudinal
mentorship of research protocols, and anonymous precourse and postcourse surveys. The paired t-test was
used to analyze the change in academic self-efﬁcacy scores.
RESULTS Fourteen Zambian clinical oncology fellows participated. Senior fellows were paired with research
mentors, leading to the development of eight research protocols. A total of 70 meetings and 126 hours of
mentorship occurred with a median of seven meetings and 15 hours per pairing. The precourse and postcourse
survey response rates were 86% and 79%, respectively. There were statistically signiﬁcant increases in
nine of 12 academic self-efﬁcacy domains. The largest gains were in ability to independently perform research
(P , .001) and research mentorship (P = .02) with an average increase of 1.5 points on a ﬁve-point scale in both
domains.
CONCLUSION The Cancer Diseases Hospital MD Anderson Cancer Center clinical research training program for
Zambian clinical oncology fellows led to increases in multiple academic self-efﬁcacy domains among participants, formation of longitudinal mentorship groups with both faculty and peer mentors, and development of
Zambian-led research protocols, demonstrating the feasibility of implementing a virtual model. This may be
especially relevant because of shifting international collaboration paradigms after the COVID-19 pandemic.
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The burden of cancer is quickly growing in Africa and
presents a signiﬁcant public health challenge to the
continent today and in the coming decades if the
status quo remains.1 Although cancer has historically
received less attention and resources because of the
competing risk of communicable diseases in Africa,
the present-day risk of mortality from cancer among
African women is already similar to that of North
American women, demonstrating the immediacy of
the problem.2,3 Furthermore, countries located in subSaharan Africa are projected to have the greatest
relative increase in global cancer incidence between
2020 and 2040 by a signiﬁcant margin, which
will exacerbate existing limitations in cancer care.3
Clinical research is essential to develop effective,
evidence-based interventions to the unique cancer

care challenges that occur in Africa and should be
prioritized. Rather than being regarded as a luxury
because of a shortage of resources, it is counterintuitively more important to appropriately allocate
scarce resources and develop cost-effective and
culturally aligned solutions.4
African countries, however, are signiﬁcantly underrepresented in cancer research because of historical
and persistent inequalities.5,6 Barriers to clinical research in Africa include lack of adequate funding to
build research infrastructure, procure equipment,
implement high-quality training programs, maintain
research personnel and collaborations, and consistently collect health data.1 Among these, training
physicians in clinical research has been identiﬁed as a
sustainable method to strengthen clinical research
capacity as local physicians are best equipped to
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CONTEXT
Key Objective
To determine whether a virtual format is a feasible and effective format for an international clinical research training program
for clinical oncology fellows at a cancer teaching hospital in Zambia.
Knowledge Generated
A virtual clinical research training program for Zambian oncology fellows had key advantages over an in-person format,
including the ability to leverage the full breadth of the institution to identify lecturers and mentors, allow for longitudinal
collaboration, and reduce costs associated with implementation. The program led to marked increases in academic selfefﬁcacy domains among participants, development of Zambian-led research protocols, and support through longitudinal
mentorship by peer trainee and faculty mentors.
Relevance
A virtual clinical research training model is feasible and effective and has certain advantages over an in-person format, which
may be especially relevant because of shifting international collaboration paradigms because of the COVID-19 pandemic.

deﬁne and investigate important research issues within
their own country. 7,8 There have been numerous successful partnerships between developed countries and
countries in Africa for the training of doctoral fellows,
epidemiology and operational researchers, and health
care workers.9-16 However, there are few published
experiences of clinical research training programs for
African oncologists, and even fewer delivered through a
virtual platform.
The MD Anderson Cancer Center (MDA) in Houston, TX,
and the Cancer Diseases Hospital (CDH) in Lusaka,
Zambia, have an established academic partnership that
includes telehealth mentoring through Project ECHO17 and
an annual high-yield course in radiation biology and
physics.18 The CDH Specialized Training Program in
Clinical and Radiation Oncology enrolled its ﬁrst fellows in
2018 and will graduate the country’s ﬁrst cohort of locally
trained oncologists in 2022. A signiﬁcant area of need was
jointly identiﬁed as a structured clinical research training
program. Here, we describe the implementation and results
from the initial yearlong virtual clinical research training
program for Zambian clinical oncology fellows created as a
collaboration between MDA and CDH.
METHODS
Training Program and Participants
The virtual clinical research training program consisted of
ﬁve core components (Fig 1), including (1) the weekly
virtual lecture series, (2) development of research questions by the Zambian oncology fellows, (3) identiﬁcation
and assignment of faculty and peer mentors, (4) joint
longitudinal mentorship of research protocols, and (5)
mixed qualitative and quantitative anonymous precourse
and postcourse surveys. The Zambian oncology fellows
were given protected time to attend the lecture series, and a
requirement for graduation was the completion of a research thesis.

Virtual Lectures
The lecture component consisted of 14 weekly lectures that
were delivered over teleconference (Zoom Video Communications Inc, San Jose, CA). The lecture topics were
chosen by a core group of senior faculty from MDA and
CDH. The lectures were given by nine different MDA faculty
members, one CDH faculty member, and one MDA resident physician. One session was led by CDH fellows presenting their research proposals. The lectures were broadly
categorized into foundational and advanced topics
(Table 1). The foundational topics focused on research
skills that could be interdisciplinary, with incorporation of
examples involving oncology, whereas the advanced topics
developed more speciﬁc clinical or radiation oncology research skills. Each session was allotted up to 90 minutes of
time, with the lecture component generally lasting between
30 and 60 minutes and additional questions and discussion another 30 minutes.
Mentorship Program
Although all Zambian oncology fellows were encouraged to
participate in the training program, only senior oncology
fellows were expected to develop a research question and
be paired with research mentors. Fellows initially developed
a research question during the weekly lecture series with
assistance from CDH faculty supervisors. Afterward, they
were assigned to both an MDA faculty and an MDA peer
mentor (a resident or fellow in an oncologic discipline at
MDA with a background in clinical research). Mentor
groups were encouraged to meet every 2-3 weeks on a
virtual platform to develop and execute their research
protocol. Peer mentors were elicited for feedback at regular
intervals and asked to estimate their total number of research meetings and hours spent mentoring.
Survey Design and Analysis
Under institutional review board approval and with written
consent, anonymous precourse and postcourse surveys
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FIG 1. The CDH-MDA virtual clinical research training program schema. CDH, Cancer Diseases Hospital; MDA, MD Anderson Cancer Center.

TABLE 1. Virtual Lecture Series Foundational and Advanced Topics and Speakers
Week

Lecture Title

Speaker (degree)

Foundational
topics
1

Introduction to Clinical Research

L. Lin (MD)

2

Choosing a Mentor and Identifying a
Research Question

K. Diao (MD)

3

Critically Evaluating a Research Paper
and Designing a Retrospective Study

K. Diao (MD)

4

Research Types and Study Design

D. Lombe (MD)

5

IRB Ethics and Human Subjects
Protection

M. Chambers
(DMD, MS)

6

Introduction to Biostatistics

R. Tidwell (MS)

7

Scientiﬁc Writing Part I

C. Cameron
(PhD)

8

Scientiﬁc Writing Part II

C. Cameron
(PhD)

9

Research Protocol Review

Zambian
Oncology
Fellows

Advanced topics
10

The Process and Value of Conducting QI J. Taylor (MD)
Studies

11

Study of HIV-Related Malignancies

E. Chiao (MD,
MPH)

12

Patient-Reported Outcomes

G. Smith (MD,
PhD, MPH)

13

Medical Physics Research

L. Court (PhD)

14

Phase I/II Clinical Trial Design

T. Yap (MBBS,
PhD)

were administered electronically via Research Electronic
Data Capture before and after the lecture series. Both
surveys included 12 5-point Likert scale academic selfefﬁcacy questions (Data Supplement). The precourse
survey included background research experience questions, and the postcourse survey included six 5-point Likert
scale questions on course feedback in addition to openended feedback questions. The paired t-test was used to
test differences in precourse and postcourse academic
self-efﬁcacy inventory scores, with P , .05 considered
statistically signiﬁcant.
RESULTS
The initial yearlong training program took place between
August 2020 and July 2021 with the weekly lecture series
occurring between August 2020 and November 2020 and
was attended by all 14 Zambian clinical oncology fellows at
the time. This included eight senior (second or third year)
and six junior (ﬁrst year) fellows in the 4-year program.
At the conclusion of the weekly lecture series, all eight
senior fellows had developed a research question and were
successfully paired with a local Zambia faculty mentor, a
MD Anderson faculty mentor, and a MD Anderson peer
trainee mentor on the basis of their area of research interest. Between November 2020 and July 2021, a total
of 70 virtual meetings and 126 hours of mentorship occurred. The median number of meetings and hours of
mentorship for each pairing were seven (range, 3-21) and
15 (range, 8-38) hours, respectively. Table 2 lists the
current Zambian fellow-led active research proposals including their progress as of August 2021.
The precourse survey response rate was 12 of 14 (86%),
and the postcourse survey response rate was 11 of
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TABLE 2. Active Zambian Oncology Fellow–Led Research Protocols, Objectives, and Progress
Research Protocol Title

Study Design

Objectives

Current Progress

Retrospective evaluation of toxicity outcomes for Retrospective Primary: to review dosimetric parameters (point
2D v 3D planning for locally advanced cervical
A, bladder point, rectal point, D2cc bladder,
cancer brachytherapy
D2cc rectum, D90 CTV, and V100 CTV)
achieved for each patient in brachytherapy
plans
Secondary: overall survival and progression-free
survival

Data collection (late phase)

Measuring the overall beneﬁt of 3D planning for Retrospective Primary: to compare planning parameters (plan
breast radiotherapy in a resource-limited
evaluation) between 2D and 3D plans
environment
Secondary: to report on clinical outcomes of
patients treated with 2D plans and correlate
with dosimetric parameters

Data retrieval

Overall survival and outcomes in patients with
geriatric cancer at the CDH

Data retrieval

Retrospective Primary: to evaluate the impact of therapy or
disease on function and cognition
Secondary: to assess factors that are associated
with improved clinical outcomes

Retrospective study to evaluate the causes of Retrospective Primary: to evaluate causes of mortality for
mortality for patients with cervical cancer
patients with cervical cancer treated at CDH
during chemoradiation and within the acute
who died during or within 3 months after
period after treatment completion
chemoradiation between 2006 and 2019

Data collection (early phase)

A retrospective study of de novo metastatic
breast cancer at the CDH: Do
sociodemographic factors play a role in late
presentation?

Retrospective Primary: to determine sociodemographic factors
that contribute to late presentation and
diagnosis among women with de novo
metastatic breast cancer
Secondary: to determine the overall survival for
patients with de novo metastatic breast
cancer at the CDH

Data retrieval

Retrospective study to evaluate factors
contributing to advanced-stage presentation
of pediatric patients with retinoblastoma

Retrospective Primary: to determine the stage and outcome of
pediatric patients presenting at the CDH with
retinoblastoma between 2000 and 2020
Secondary: to determine the cause of advancedstage presentations, assess practices of
retinoblastoma screening among health care
workers in the county, and establish
measures with the Ministry of Health for early
detection of pediatric retinoblastoma

Literature review completed

The inﬂuence of time from preoperative
chemoradiation to surgery on rectal cancer
outcomes

During data retrieval, missing data led
Retrospective Primary: to assess the inﬂuence of time from
to conception of prospective quality
preoperative chemoradiation to surgery on
improvement project to improve
pathologic response of rectal cancers
patient follow-up
Secondary: to assess the average time from
completion of preoperative chemoradiation to
surgery among patients with rectal cancer at
the CDH

Corrigendum of FIGO staging and its impact on Prospective
management of cervical carcinoma at the
CDH

Primary: to evaluate changes in staging patterns,
diagnosis, and treatment at the CDH over time
Secondary: to assess the impact of CT scan on
clinical staging of patients with cervical
cancer

Study IRB proposal under review

Abbreviations: 2D, two-dimensional; 3D, three-dimensional; CDH, Cancer Diseases Hospital; CT, computed tomography; CTV, clinical target volume; FIGO,
International Federation of Gynecology and Obstetrics; IRB, institutional review board.

14 (79%). All survey nonrespondents were ﬁrst-year fellows. None of the respondents reported previous participation in clinical research projects or lectures on clinical
research or statistical methods.
Average scores precourse and postcourse for the 12
Likert scale academic self-efﬁcacy questions are reported with statistically signiﬁcant increases in nine

domains including comfort in interpreting research;
ability to generate a research hypothesis, develop a
research question, collect and maintain data, summarize and report data, publish results of research, and
independently perform research; the presence of research mentorship and guidance; and professional
satisfaction (Fig 2).

4 © 2022 by American Society of Clinical Oncology

Downloaded from ascopubs.org by University of Texas MD Anderson Cancer Center on May 23, 2022 from 143.111.084.161
Copyright © 2022 American Society of Clinical Oncology. See https://ascopubs.org/go/authors/open-access for reuse terms.

Virtual Clinical Research Training Program in Zambia

The largest gains were noted in ability to independently
perform research and the presence of research mentorship
with an average increase of 1.5 points in both domains
postcourse compared with precourse. In the three domains
without a statistically signiﬁcant difference, both high
baseline and postcourse scores were observed in perception of research importance, motivation to read medical
research, and interest in conducting research.
In the postcourse survey, the average Likert scale scores for
“I have more knowledge about research after taking the
course,” “The course stimulated a greater interest in me for
research,” and “I would recommend this course to others”
were 4.5 of 5.0, 4.8 of 5.0, and 5.0 of 5.0, respectively.
Representative anonymous comments of individual respondents from the precourse survey and positive and
constructive feedback from the postcourse survey are
summarized in Table 3. For example, respondent 1 stated “I
am hoping to gain the knowledge of conducting clinical
research and how to statistically analyze data” before the
start of the lecture series and “The course has made me
comfortable in analyzing any research paper and to write my
research proposal” after the conclusion of the lecture series
but desired “More time spent on research data analysis.”
Challenges identiﬁed by MDA peer mentors included the
logistical difﬁculties associated with ﬁnding mutual times to
meet because of busy clinical schedules and the time
difference, perceived lack of protected time for faculty and
registrars to meet and conduct research, limited experience
of the mentees with practical topics such as literature review and data analysis, need for formal statistical support,
and concerns regarding data quality and infrastructure.
DISCUSSION
The virtual CDH-MDA clinical research training program for
Zambian oncology fellows led to marked increases in
multiple academic self-efﬁcacy domains among participants, formation of longitudinal mentorship groups with
both peer trainees and faculty mentors, and development
of numerous Zambian-led research protocols, demonstrating the feasibility of implementing a virtual clinical
research training model, which may be especially relevant
because of shifting international collaboration paradigms as
a result of the COVID-19 pandemic.19 The burden of cancer
in Africa is well-documented to be increasing rapidly, and
among low human development index countries, most of
which are located in sub-Saharan Africa, the incidence of
cancer is projected to increase by 95% between 2020 and
2040.3 Despite this, Africa is responsible for only 2% of all
research output globally.20 Developing local clinical research capacity has been identiﬁed as an important means
to allow countries to deﬁne their own greatest health issues,
propose cost-effective and evidence-based solutions, implement the interventions, and investigate their impact.21
The CDH-MDA academic partnership was ﬁrst established
in 2015 and has included in-country clinical education

workshops and telementoring17 and an annual radiation
biology and physics course.18 In addition, core faculty
members from CDH and MDA meet weekly via teleconference to discuss joint initiatives and research. We found that
the longstanding partnership between CDH and MDA and
consistent communication were instrumental in the success
of the present program by allowing for shared planning and
program development, allocation of resources (ie, protected
time for registrars), and rapid response to issues as they
arose. The clinical research training program was initially
planned to be an in-person workshop taking place over one
week, but because of the ongoing COVID-19 global pandemic, the workshop was adapted to a virtual format. We
found that a virtual format provided several key advantages,
including the ability to engage true content experts to deliver
the weekly lectures, leverage the full breadth of the institution
to identify faculty mentors for all senior Zambian oncology
fellows, engage peer trainee mentors in the program, allow
for longitudinal collaboration over the course of the year, and
reduce costs associated with implementation. For example,
the biostatistics lecture was given by a senior biostatistician
with a degree in education, the scientiﬁc writing lectures by a
National Institutes of Health–funded investigator of scientiﬁc
communication, the research ethics lecture by the Chairman
of the MDA institutional review board, and the clinical trials
lecture by a faculty participant in the ASCO/American Association for Cancer Research Methods in Clinical Cancer
Research Workshop.22
There is growing interest in global health among US health
professional trainees, and it is increasingly viewed as a
viable academic career pathway.23 We found that the peer
mentorship program generated signiﬁcant, bilateral value
by providing US peer mentors with a global health experience that can serve as a foundation for future academic
opportunities and providing Zambian mentees with a highly
accessible mentor at a comparable level of training. Peer
mentorship has several distinct advantages, including
being more approachable, increased time available for oneon-one teaching, closer proximity to age of mentee and
level of understanding of subject matter, and high levels of
energy and enthusiasm. Importantly, all peer mentors
serving in the program had signiﬁcant clinical research
experience including previous peer-reviewed publications.
The Zambian oncology fellows were able to receive a level of
guidance on their research protocols that would have been
difﬁcult to provide with a faculty mentor alone. Mentors
found that ﬂexibility with the route of communication was
helpful, as the Zambian fellows were typically more comfortable communicating through mobile apps than e-mail.
Still, mentors noted challenges with coordinating meetings
and responsiveness to communication, which might have
in part been due to cultural factors that can signiﬁcantly
affect the mentorship relationship.24 As a result, we are
implementing a global, culturally sensitive mentorship
curriculum for peer mentors in the program.
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FIG 2. Average scores precourse (left hashmark within each category) and postcourse (right hashmark within each category) for 5-point Likert scale
academic self-efﬁcacy domains. NS, not signiﬁcant.

We found high rates of baseline perception of research
importance and interest in clinical research among all
respondents. Although other similar training programs
have used a competitive application process for selection of participants, our results demonstrate that even
among an unselected group of postgraduate physician
trainees in Africa, there may be high rates of perception
of research importance and that furthermore, participating in a structured research training program may

foster an interest in research that would not have otherwise occurred without the opportunity to participate in
research.25 However, baseline scores in other clinical
research domains were lower and demonstrated statistically signiﬁcant gains postcourse compared with
precourse. The largest numeric gains were made in
ability to independently perform research and the
presence of mentorship with an average increase of
1.5 points in both domains on a 5-point scale postcourse

TABLE 3. Representative Anonymous Feedback and Comments From Precourse and Postcourse Surveys
Respondent

Precourse Comments

Positive Feedback

Constructive Feedback

The course has made me comfortable in
analyzing any research paper and to write
my research proposal

More time spent on research data analysis

1

I am hoping to gain the knowledge of
conducting clinical research and how to
statistically analyze data

2

To be able to generate a research question, The fact that we were given an opportunity to Include topics on basic research statistics.
review literature and conduct a successful
present our cases were others could
To spend more time on the basics for
example on P values, hazard ratios,
research project
comment, that really helped a lot. Also the
lectures were so helpful, well broken down to
conﬁdence intervals, ie, what they are
our level of understanding
with some examples and how to use them

3

More emphasis on the methodology of
Very enthusiastic to know more about clinical Going through the research projects topics
research and methodology and kick start a
proposed and exemplifying on how it is done
clinical research, statistical analysis and
research project in the near future
its signiﬁcance

4

To have lectures on research early on at the
I want to be able to complete my research The interactive sessions that we had with
beginning of the academic year. How to
thesis and to have more understanding of
different presenters. Being paired with
write an effective research proposal and
research methodology
mentors from MD Anderson helped me to
perform a literature review and citation
start with my project. Through the meetings I
am able to learn how to improve my research
proposal

5

By the end of this training I hope I’ll be able to The course was well organized, all topics were Physical lectures could be more interactive.
formulate a research question and work on
well covered
How to write a literature review, data
it. This is a long awaited workshop, I am
collection tools and methods
really enjoying the lectures so far. A big
thank to our mentors both local and
international
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compared with precourse, indicating a highly relevant
difference. These results suggest that our weekly lecture
series and longitudinal mentorship program were successful in developing research skills.
Positive themes from open-ended postcourse feedback
included clear lectures, meaningful relationships with
mentors, and utility of presenting research proposals for
feedback, whereas constructive themes included desire
for more teaching on foundational topics, including statistical analysis, literature review, and data collection, and
incorporation of self-assessment modules, which will be
addressed in subsequent years of the program. Other research programs in development should consider spending
additional time on fundamental research skills in this
trainee population. Although the progress made in active
research protocols thus far has been modest, with the most
advanced protocol to date nearing the completion of data
collection and no protocols having yet been completed, the
Zambian clinical oncology fellows are also juggling a fulltime clinical load and examinations. Our experience
demonstrates an achievable yearlong timeline for research
among clinical trainees and can be used to establish goals
for other nascent training programs. The timeline also
highlights the importance of initiating trainees in research
early on in their program, longitudinal mentorship, and a
long-term collaboration between partner institutions.
There have been numerous successful research training
partnerships between developed countries and countries in
Africa.9,10,14-16 Although these initiatives have shown the potential positive impact of north-south research partnerships,
there remains a clear need for highly accessible clinical research training among African oncology fellows. However, to
our knowledge, the only other published experience of a
distant clinical research training program for oncology trainees
has been the Accra-Toronto collaboration.25 This initiative by
Vulpe et al involved a distant clinical research curriculum for
ﬁve Ghanaian radiation oncology residents with 13 weekly
seminars over videoconference followed by a 1-year long
mentorship program for the top two residents. At the end of the
program, two manuscripts were ﬁnalized and one was published. The Accra-Toronto collaboration and the present CDHMDA partnership share core principles, and the success of
both programs strengthens the case for the effectiveness of a
distant-learning partnership model of clinical research training.
Differences between the CDH-MDA partnership and AccraToronto collaboration include size (14 v ﬁve participants), allocation of mentorship (all eight senior fellows v the top two
residents), and type of mentorship (combined faculty and peer
v faculty only), respectively. There are merits for both the more
inclusive CDH-MDA approach and the more selective AccraToronto approach, and either can be considered when developing a program on the basis of available resources and
program goals.
Semistructured interviews with participants will be performed to understand the experience of African oncology

trainees in a virtual, international clinical research training
program, the results of which will be reported separately
and will guide expansion of the program in subsequent
years. A virtual education platform will host high-ﬁdelity
studio recordings of lectures; additional lectures on biostatistics, literature review, and data management; individual self-assessment modules; and a handbook on
biostatistical methods. These resources will be made
publicly available. Funding support will be available for
resulting abstracts, conference presentations, and manuscripts. Future goals include the development of culturally
sensitive training programs for peer mentors and establishment of structured mentorship expectations, goals, and
timelines. The role of an in-person component to the
program will be re-evaluated after the COVID-19 pandemic.
There was no competitive application process, meaning that
participants were unselected in terms of level of interest in
clinical research—this may represent a strength (inclusiveness
and part of core fellowship curriculum, particularly important
given the small number of oncologists in Africa and need to
train leaders in clinical research) or limitation (more resourceintensive, relatively less likely to lead to a publication for the
effort) depending on the context. The results described here
were at the end of the initial year of the training program, and
longer-term follow-up will be required to determine the impact
of the course on participant careers, research productivity, and
patient care in Zambia. There were shortcomings with the
initial training program that we were made aware of through
feedback from participants and mentors, which included
topics that needed to be covered in greater detail, desired
resources, and challenges with mentorship including baseline
research knowledge, communication, and ﬁnding time to
meet. We hope to address many of these issues in subsequent
iterations of the training program.
In conclusion, clinical research rwill be essential to develop
effective, evidence-based interventions to confront the
rising burden of cancer and unique cancer challenges in
Africa. The results from the initial virtual CDH-MDA clinical
research training program for Zambian clinical oncology
fellows, which led to marked increases in multiple academic self-efﬁcacy domains, formation of longitudinal
mentorship groups, and development of numerous
Zambian-led research protocols, demonstrate the feasibility
of implementing a virtual clinical research training model
that features peer trainee mentors. A virtual approach has
key advantages including ability to (1) engage content
experts to deliver lectures, (2) leverage the full breadth of
the institution to identify faculty and peer mentors, (3) allow
for longitudinal collaboration, and (4) reduce costs associated with implementation. Our model can be a framework
for other initiatives that seek to increase clinical research
capacity in Africa during and after the era of COVID-19 with
shifting international collaboration paradigms.
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